Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 TRACON PharmaceuticalsEnzon PharmaceuticalsCytRxTrovaGeneAIM ImmunoTech
SymbolNASDAQ:TCONOTCMKTS:ENZNOTCMKTS:CYTRNASDAQ:TROVNYSE:AIM
Price Information
Current Price$3.81$0.20$0.59$1.66$1.07
52 Week RangeBuyN/ABuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$12.50N/AN/A$14.50$4.50
% Upside from Price Target228.08% upsideN/AN/A773.49% upside320.56% upside
Trade Information
Market Cap$12.65 million$8.93 million$20.35 million$12.85 million$8.59 million
Beta2.01-0.061.710.450.75
Average Volume380,71033,627138,923988,2055,537,183
Sales & Book Value
Annual Revenue$3 million$210,000.00$250,000.00$380,000.00$370,000.00
Price / Sales3.9942.5479.3933.8123.89
CashflowN/A$0.13 per shareN/AN/AN/A
Price / CashN/A1.56N/AN/AN/A
Book Value$7.18 per share$0.14 per share$0.61 per share$2.63 per share$4.73 per share
Price / Book0.531.440.970.630.23
Profitability
Net Income$-34,960,000.00$5.85 million$-12,710,000.00$-16,460,000.00$-9,810,000.00
EPS($13.00)N/A($0.29)($8.26)N/A
Trailing P/E RatioN/A1.44N/AN/AN/A
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-3,797.67%N/A
Return on Equity (ROE)-215.39%-10.79%-31.45%-185.18%-159.40%
Return on Assets (ROA)-85.47%-9.00%-27.75%-119.86%-60.22%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.84%N/AN/A0.16%0.33%
Current Ratio1.58%14.17%6.36%2.39%3.01%
Quick Ratio1.58%1.93%6.36%2.39%3.01%
Ownership Information
Institutional Ownership PercentageN/A0.01%2.22%12.14%15.42%
Insider Ownership Percentage23.30%0.06%6.90%2.00%14.96%
Miscellaneous
Employees26N/A6N/A31
Shares Outstanding3.14 million44.22 million33.64 million7.74 million8.26 million
Next Earnings Date2/27/2020 (Confirmed)N/A4/3/2020 (Estimated)3/4/2020 (Estimated)4/6/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel